bariatric artery embolization - search results
If you're not happy with the results, please do another search
Using Y-90 to achieve bariatric artery radioembolization
Nearly 10 years have passed since Aravind Arepally et al published data from the first gastric artery chemoembolization preclinical trials for the treatment of...
Bariatric gastric artery embolization can modulate “hunger hormone” levels
Charles Kim, Durham, USA, and colleagues, have identified some of the sequelae of gastric artery embolization for systemic suppression of the hunger hormone, ghrelin. The researchers have used a porcine model.
Bariatric embolization: What we know so far
Obesity has been steadily increasing worldwide for at least 50 years. It directly contributes to the rising incidence of cardiovascular, musculoskeletal, and oncological diseases....
Gastric embolization unfit as standalone obesity treatment
Determining the potential role of interventional radiologists in obesity treatment is increasingly important, as the global number of obese patients has long since swollen...
Bariatric embolization: Promising results for GET LEAN study at six months
by Sumeet Patel, Azim Shaikh and Mubin Syed
The GET LEAN (Gastric artery embolization trial for the lessening of appetite nonsurgically) study shows promising six-month preliminary data...
Doctors perform first US bariatric embolization procedure to treat obesity
Bariatric embolization is the first catheter-based procedure that attempts to directly address obesity. The minimally invasive technique is expected to decrease the hormone ghrelin, responsible for appetite, resulting in weight loss.
Cryovagotomy may help ignite weight loss
Cryoablation of the posterior vagal trunk, the nerve carrying hunger signals to the brain, may help patients with mild-to-moderate obesity lose weight, according to...
Interventional News’ top 10 most popular stories of March 2023
Interventional News’ most popular stories from March included those covering new embolization and radiofrequency ablation data presented at the Society of Interventional Radiology (SIR)...
Persistence, persistence, persistence: Lessons in device innovation from three prolific inventors
Timothy Clark, director of Interventional Radiology at Penn Presbyterian Medical Center, Philadelphia, USA and co-founder and chief executive officer of Forge Medical, which has...
Gregory John Slater
"War (as in turf war) is an emotional word because, in wars, people get hurt. I believe we truly care about the patients we...
BEAT Obesity 30-day safety data presented at SIR
BEAT Obesity is a physician-sponsored investigational device exemption single-arm prospective clinical trial for five to 15 morbidly obese patients using used (off-label) is 300‰ÛÒ500ë_m Embosphere microspheres (Merit Medical).
A catheter to curb your appetite?
A retrospective study reports that individuals who underwent embolization of the left gastric artery for gastrointestinal bleeding experienced a 7.9% decrease in body weight, three months after the procedure. Could embolization of the left gastric artery be used in the treatment of obesity?
